ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105348 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105348; 2) Community: the network communities that were significantly associated with the response to NSC 105348; 3) Molecule: the relationships between components within communities and NSC 105348; 4) MDR: the compounds that were significantly associated with the NSC 105348.

NSC Compound Enrichment Correlation
NSC 157995 Benzo[c]phenanthridinium, 2-hydroxy-3,8,9-trimethoxy-5-methyl-, chloride (9CI) (MF1) 0.0171381695159494 0.29789214
NSC 357704 Cyanomorpholinodoxorubicin 0.0171381695159494 -0.06905337
NSC 681239 Bortezomib 0.0171381695159494 0.051927492
NSC 696075 Null 0.0171381695159494 -0.28353095
NSC 713197 Benzo[g]quinoxaline-2,3-dicarboxylic acid, 5,10-dihydro-5,10-dioxo-, diethyl ester 0.0171381695159494 -0.10499523
NSC 722052 (-)-Dibenzylnortrachelogenin 0.0171381695159494 -0.33363699
NSC 736739 E2GG, 5,7-bis[(4-methoxybenzyl)amino]-3-isopropylpyrazolo[4,3-d]py rimidine 0.0171381695159494 -0.20043201
NSC 740618 (Z)-1-(2-chloro-5-(trifluoromethyl)phenyl)-4-(2-hydroxybenzylidene)-2-phenyl-1H-imidazol-5(4H)-one 0.0171381695159494 0.28862547
NSC 745929 Null 0.0171381695159494 -0.039066205
NSC 756078 1-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole 0.0171381695159494 -0.23195535
Total:43  Current:15    [First] [Prev] [Next] [Last]